What Researchers Did
Researchers studied if hyperbaric oxygen therapy could help patients with schizophrenia or vascular mental disorders who were not responding to standard psychiatric medications.
What They Found
A positive clinical effect was observed in 72.5% of all patients, including 67.4% of schizophrenic patients and 77.4% of patients with vascular mental disorders. The study concluded that HBOT helped shorten hospital stays and improved both clinical and social outcomes for these patients.
What This Means for Canadian Patients
For Canadian patients struggling with mental disorders like schizophrenia or vascular mental disorders who haven't responded to standard medications, this study suggests HBOT might offer a new treatment option. It indicates potential benefits such as shorter hospital stays and improved overall well-being.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This older observational study from 1996 does not provide details on its design, specific HBOT protocols, or long-term patient outcomes.